Sign in / Join Now
ETFs & Funds
As far as
, they have a huge problem with Jakafi. For details, look at youtube video by Dr. Pardanani, who is @ Mayo.
Jakafi is a terrible drug for MF and should not have been approved by the FDA. This makes other indications for Jakafi very questionable.
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
The New #38 Most Shorted Nasdaq 100 Component: Incyte
at TheStreet (Wed, 3:20PM)
Incyte Breaks Above 200-Day Moving Average - Bullish for INCY
at Nasdaq.com (Jul 21, 2016)
Amgen, Incyte Well Positioned Following Brexit
at Benzinga (Jun 29, 2016)
Incyte Gains on Jakafi's Breakthrough Status for Acute GVHD
at Zacks.com (Jun 24, 2016)
Incyte Reports Epacadostat Combination Study Initiation
at Zacks.com (Jun 23, 2016)